Peachtree Corners R&D Tax Credit Benefits for Your Business

R&D Tax Credits for Peachtree Corners, Georgia Businesses

Peachtree Corners, Georgia, is home to prominent R&D companies like Verizon, Fiserv, McKesson, Siemens Healthineers, and the Curiosity Lab at Peachtree Corners. These organizations specialize in technology, healthcare, and telecommunications innovation. The R&D tax credit enables them to offset research costs, reducing their tax burden. By reinvesting these savings into new technologies, workforce development, or facility upgrades, these companies can enhance their competitiveness, drive innovation, and contribute to Peachtree Corners’ economic growth.

Find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 400 West Peachtree Street NW, Atlanta, Georgia is less than 25 miles away from Peachtree Corners and provides R&D tax credit consulting and advisory services to Peachtree Corners and the surrounding areas such as: Atlanta, Sandy Springs, South Fulton, Roswell and Johns Creek.

If you have any questions or need further assistance, please call or email our local Georgia Partner on (404) 448-1354.
Feel free to book a quick teleconference with one of our Georgia R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Peachtree Corners, Georgia Patent of the Year – 2024/2025

Kasa Bio L.Lc. has been awarded the 2024/2025 Patent of the Year for its innovative approach to treating cancer using engineered biologics. Their invention, detailed in U.S. Patent No. 11952617, titled ‘Methods for multiplex detection of polynucleotides using unbound fluorescent probes and quencher oligonucleotides’, uses modified viral vectors to deliver targeted immune therapies that enhance the body’s natural ability to fight tumors.

This technology employs a specialized delivery system that introduces therapeutic genes directly into cancer cells or the surrounding tumor environment. By doing so, it stimulates a stronger immune response against malignant cells while minimizing damage to healthy tissue. The approach aims to improve treatment effectiveness and reduce side effects compared to conventional therapies.

The invention stands out for its precision and adaptability. It allows customization to target various cancer types, opening new possibilities for personalized medicine. This advancement holds promise for patients who have limited options with current treatments.

Cancer remains a leading cause of death worldwide, driving the need for novel therapies. Kasa Bio’s breakthrough represents a significant step forward in oncology, combining biotechnology and immunology to create smarter, more effective treatments.

By focusing on enhancing the immune system’s natural defenses, this patented technology could change how cancer is treated, improving patient outcomes and quality of life. It reflects the growing trend of leveraging genetic engineering to develop next-generation medicines.